Caris Life Sciences to Showcase Research at 2024 SGO Annual Meeting on Women's Cancer

Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI, announced today that the company and collaborators within the Caris Precision Oncology Alliance™ (POA) will collectively present three studies across multiple gynecological tumor types at the 2024 SGO Annual Meeting on Women's Cancer, Ma

Related Keywords

New York ,United States ,Tokyo ,Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,Switzerland ,Phoenix ,Arizona ,Texas ,Lisa Burgner ,Caris Life Sciences ,Walking Poster Session Group ,Caris ,Caris Life Sciences Media Contact ,Chief Medical Officer George ,Poster Session ,Walking Poster Group ,Cancer Care ,Proactive Molecular Risk Classifier ,Endometrial Cancer ,Whole Exome ,Whole Transcriptome Sequencing ,Life Sciences Media Contact ,